Deciphera is presenting preclinical data for DCC-3084 at the American Association for Cancer Research (AACR) Annual Meeting 2024, on Sunday, April 7 in San Diego, CA. #AACR24
Deciphera Pharmaceuticals’ Post
More Relevant Posts
-
This week’s new issue of #ScienceSignaling is out now! A preclinical study offers insights into the origins of resistance to MAPK inhibitors in cancer cells, our new Editors’ Choice piece highlights research on the role of lactate in cancer-associated cachexia, and more. https://scim.ag/6X4
To view or add a comment, sign in
-
-
Learn more about the @NCI #FundingOpportunity that supports preclinical research projects investigating mechanisms of immunoprevention and developing immunoprevention strategies, which will form the Cancer Immunoprevention Network (CIP-Net). https://lnkd.in/e5my5Yei
To view or add a comment, sign in
-
-
Dear All, We are happy to share BIPR’s *5th research paper publication in current academic year 2023-24* Heartiest Congratulations to Principal *Dr. Vinod S. Mule* for research paper being published in *International Journal of Trends in OncoScience*, 02(02)2024; Page No. 32-40, on topic *EPIGENETICS IN CANCER THERAPY* Vinod Mule #bipr #pharmacy #research #researchpaper #internationaljournal #oncoscience
To view or add a comment, sign in
-
-
Annals video summaries are systematic reviews condensed into short videos designed for busy clinicians. This video summarizes the findings of a new study investigating the benefits of participation in experimental cancer drug trials: https://ow.ly/JXUX50RtS05
To view or add a comment, sign in
-
📣 We're excited to move forward in our research exploration of combining a multi-payload linker, Multilink, with a CD37 targeted ADC against cancer. 🎥👇Our Associate principal scientist, Lisa Ivanschitz, just unveiled the first preclinical data of this investigational program, Debio 1562M, during her poster presentation this weekend at the American Society of Hematology annual meeting. Discover her introduction below of these promising results or read the full poster online ⬇ https://lnkd.in/eDpCpWEA #datarelease #preclinicaldata #drugdevelopment #antibodydrugconjugates #oncology
To view or add a comment, sign in
-
Happening tomorrow in Boston: our CSO Li Peng’s talk on glyco-immunology in cancer drug development with fellow experts in the space. We hope you can join to learn more about this exciting field! Learn more: https://bit.ly/48xrRPu #targets23
To view or add a comment, sign in
-
Learn about the latest tools and techniques for liquid biopsy analysis in our latest on-demand webinar. Explore how our Dynabeads™ magnetic beads empower the enrichment and analysis of key biomarkers like circulating tumor cells (CTCs), extracellular vesicles, and circulating tumor DNA (ctDNA). Register now to gain valuable insights into advancing cancer research!
To view or add a comment, sign in
-
Resolving Diagnostic Uncertainty - Learn more about Interpace Diagnostics' novel molecular diagnostic tests for thyroid and pancreatic cancer at FSP. https://lnkd.in/gNytsCxt #thyroidcancer #pancreaticcancer #molecular
To view or add a comment, sign in
-
-
Weekend 1/50. Deciding to make the most of the weekends this year. Made a classification model to predict Breast Cancer Progression with a 97% accuracy. #computationalbiology #artificialintelligence #machinelearning #machinelearningalgorithms #bioinformatics #clinicalresearch #cra #medicalaffairs #goodnews #researchanddevelopment #clinicaltrials
To view or add a comment, sign in